Skip to content
DeeptechNavigator

Patent intelligence · Companies

Company patent strength

Non-educational filers ranked by their patent portfolio. Grant rate and lapsed share expose where high filing volume is not matched by granted patents. Domestic filers lead — toggle to foreign applicants to see who is entering the Indian market.

Free to browse the ranking. Sign into open a filer's full profile — inventors, filing trend and quality index. See how we rank.

Why this page exists — and how to read it

Filing volume and IP quality are different things. This leaderboard ranks non-educational filers by portfolio, but the grant-rate and lapsed sorts are where the judgement lives: they separate companies whose filings survive examination from those accumulating paper.

Investors
High grant rate on steady filing usually means a real R&D engine; big volume with a high lapsed share is a red flag worth asking about.
Founders & operators
These are the incumbents and potential acquirers in your space — open a filer to see the walls you'd build against.
Corporate & R&D
Benchmark competitors' portfolios and grant rates; toggle to foreign to watch who is entering the Indian market.

💬 The grant-rate sort applies a 20-filing floor so tiny portfolios can't top the list.

Domestic (India)Foreign applicants
Portfolio sizeGrant rateLapsed

3,207 foreign filers with 5+ patents · page 50

#FilerPatentsGrantedLapsedPendingActive
2451MYCOTECHNOLOGY600%062023–2025
2452NCR VOYIX6233.3%042021–2025
2453NEC ONCOIMMUNITY AS6116.7%142021–2025
2454NEOPHORE600%152022–2025
2455NETZSCH FEINMAHLTECHNIK600%062022–2025
2456NEUROCHASE TECHNOLOGIES600%062023–2026
2457NEWTECH GROUP600%062023–2025
2458NGM BIOPHARMACEUTICALS600%062022–2024
2459NIPPON FIBER600%062022–2025
2460NIPPON LIGHT METAL6233.3%042022–2025
2461NIPPON PAINT INDUSTRIAL COATINGS600%152022–2024
2462NISSIN FOODS HOLDINGS600%062022–2024
2463NKARTA600%062022–2025
2464NOK6233.3%042022–2026
2465NRG THERAPEUTICS600%062023–2026
2466NUOVA OMPI S R L UNIPERSONALE600%062023–2024
2467NUTCRACKER THERAPEUTICS600%332022–2024
2468NUTRECO IP ASSETS600%152022–2026
2469NUTS HOLDINGS600%062022–2026
2470NYKODE THERAPEUTICS ASA600%062022–2024
2471OBRIST CLOSURES SWITZERLAND600%062022–2025
2472OERLIKON METCO US6116.7%052022–2025
2473OERLIKON METCO WOHLEN600%062023–2025
2474OETIKER SCHWEIZ6350%032022–2025
2475OJJO6116.7%052022–2023
2476OLIMENT600%062024–2026
2477OMRON600%062025–2026
2478ONCOC4600%062023–2026
2479ONCONIC THERAPEUTICS600%062023–2025
2480ORGANO6350%032022–2026
2481ORIGIN6116.7%322022–2026
2482ORUM THERAPEUTICS600%062022–2025
2483OSAKA GAS6116.7%052021–2025
2484OTIS ELEVATOR600%062022–2025
2485OTTA6350%032022–2026
2486P WAVER600%332023–2023
2487PANASONIC600%062024–2025
2488PARIKH HOLDINGS600%062022–2026
2489PATHY MEDICAL600%602022–2023
2490PFEIFFER VACUUM600%062025–2026
2491PFETCH600%062022–2026
2492PHARMA CINQ600%062023–2025
2493PHARMAZZ6116.7%052023–2025
2494PI CARDIA600%062023–2026
2495PINOTBIO600%062022–2025
2496PLATINUM PHARMA SERVICE S R L S600%152022–2024
2497POLY MED600%062022–2025
2498POLYN TECHNOLOGY600%062022–2026
2499PRO MED INSTRUMENTS600%062022–2025
2500PROGRESS RAIL LOCOMOTIVE600%062024–2024
← PreviousNext →

Educational institutes are excluded — see the institute leaderboard. Attribution is by patent assignee record; a jointly-owned patent is credited to each co-owner, so a co-filed patent counts for every company on it. "Lapsed" = abandoned, withdrawn, deemed-withdrawn or refused; "Pending" = awaiting examination or in prosecution. Want to filter by technology or value category? Browse the filer explorer →

Rankings use patent-registry status (grant rate, examination, claim depth) as a quality proxy — directional, not advice; see methodology. Read the ranking methodology →